{
  "main_header": {
    "sid": 1116980,
    "name": "Tianjin Ringpu Bio-technology Co., Ltd.",
    "stock_name": "Tianjin Ringpu Bio-technology Co., Ltd.",
    "full_name": "Tianjin Ringpu Bio-technology Co., Ltd.",
    "name_url": "stocks-analysis/tianjin-ringpu-bio-technology-co-",
    "exchange": 46,
    "exchangecode": "SHE",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "19.27",
    "chg": -0.11,
    "chgp": "-0.57%",
    "dir": -1,
    "prev_price": "19.38",
    "mcapval": "6,787.12",
    "mcap": "Mid Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100000TV1",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.26 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tianjin-ringpu-bio-technology-co--1116980-46&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tianjin Ringpu Bio-technology Co., Ltd. Reports Strong Financial Performance in Q1 2025",
        "link": "https://www.marketsmojo.com/news/mojo-premium/tianjin-ringpu-bio-technology-co-ltd-joins-reliable-performers-strategy-with-strong-financial-growth-3526158",
        "imagepath": "",
        "date": "2025-09-17 17:15:02",
        "description": "<p><strong>Tianjin Ringpu Bio-technology Co., Ltd.</strong> has showcased impressive financial results for the quarter ending March 2025, reflecting a robust growth trajectory in the pharmaceuticals and biotechnology sector. The company reported net sales of CNY 2,129.34 MM, marking a significant growth of 79.88% compared to the previous year.</p>\n\n<p>In addition to strong sales figures, <strong>Tianjin Ringpu Bio-technology Co., Ltd.</strong> achieved its highest operating cash flow at CNY 751.72 MM, indicating effective cash management and operational efficiency. The company also reported a notable inventory turnover ratio of 4.57%, suggesting that it is effectively managing its inventory levels and sales processes.</p>\n\n<p>Furthermore, the raw material costs have decreased by 1.09% year-over-year, which could positively impact the company's profit margins. The cash and equivalents for the half-year reach..."
      }
    ],
    "total": 1,
    "sid": "1116980",
    "stock_news_url": "https://www.marketsmojo.com/news/tianjin-ringpu-bio-technology-co--1116980"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Tianjin Ringpu Bio-technology Co., Ltd. Reports Strong Financial Performance in Q1 2025

2025-09-17 17:15:02

Tianjin Ringpu Bio-technology Co., Ltd. has showcased impressive financial results for the quarter ending March 2025, reflecting a robust growth trajectory in the pharmaceuticals and biotechnology sector. The company reported net sales of CNY 2,129.34 MM, marking a significant growth of 79.88% compared to the previous year.

In addition to strong sales figures, Tianjin Ringpu Bio-technology Co., Ltd. achieved its highest operating cash flow at CNY 751.72 MM, indicating effective cash management and operational efficiency. The company also reported a notable inventory turnover ratio of 4.57%, suggesting that it is effectively managing its inventory levels and sales processes.

Furthermore, the raw material costs have decreased by 1.09% year-over-year, which could positively impact the company's profit margins. The cash and equivalents for the half-year reach...

Read More

View All News